Cannabinoid Encyclopedia

Cannabinoid guide

What is Anandamide?

A clear guide to Anandamide: what it is, what researchers have studied, how strong the evidence is, and what to know about safety.

Updated July 2026 20 research sources Mostly early-stage research

The short answer

Anandamide, in simple terms

Anandamide is an endocannabinoid, meaning it is a cannabinoid-like signaling molecule made by the body. Researchers study it for possible effects, safety, and how it works in the body. Most of the current evidence is preclinical or focused on biological mechanisms. The evidence does not turn this into one proven benefit, because studies can use different products, doses, routes, people, and outcomes. 1

Choose your next step

Want the quick path or the full picture?

Use this guide the way you need to. Start with the practical question, then open the study detail only when it helps answer something about Anandamide.

Why people look into itSee the main questions before the research details. What researchers studiedSee the main areas and the evidence behind each one. Safety and limitsKeep product, dose, medications, and context in view. Open the sourcesGo directly to the studies and references used here.

Why people look into Anandamide

What Anandamide is commonly talked about for

These cards show the questions most represented in this source set. They are not a list of proven benefits, and the evidence label matters as much as the topic name.

  1. Mostly mechanism-focused

    Anandamide biology and metabolism

    This is part of the biological explanation for why Anandamide may have effects in cells or models. Mechanism research does not by itself show a health benefit in people. 2

    See research areas

  2. Too limited for a firm answer

    CB2

    Researchers have examined Anandamide in connection with CB2. The source details determine whether that is a human finding, an early model, or an open question. 3

    See research areas

  3. Too limited for a firm answer

    GPR119

    Researchers have examined Anandamide in connection with GPR119. The source details determine whether that is a human finding, an early model, or an open question. 4

    See research areas

  4. Too limited for a firm answer

    TRPV1

    Researchers have examined Anandamide in connection with TRPV1. The source details determine whether that is a human finding, an early model, or an open question. 5

    See research areas

Bottom line: Start with the exact question you care about, then check the study type, product, dose, and outcome before treating a research signal as a real-world effect.

Key takeaways

What to know first

  1. 1

    Research on Anandamide covers Anandamide biology and metabolism, CB2, and GPR119; those areas should not be combined into one claim. 1

  2. 2

    Most of the current evidence is preclinical or focused on biological mechanisms. 2

  3. 3

    Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3

Research areas

What has Anandamide been studied for?

These are the main questions represented in the current literature. Each link opens a source used to build the overview.

Mostly mechanism-focused

Anandamide biology and metabolism

Researchers have examined Anandamide in connection with Anandamide biology and metabolism. The studies may differ in compound, formulation, dose, route, population, and outcome. 2

Too limited for a firm answer

CB2

Studies connect Anandamide with CB2 at the level of receptors, enzymes, signaling, or pharmacology. This helps explain how the biology might work, but it does not prove a health outcome. 3

Too limited for a firm answer

GPR119

Studies connect Anandamide with GPR119 at the level of receptors, enzymes, signaling, or pharmacology. This helps explain how the biology might work, but it does not prove a health outcome. 4

Too limited for a firm answer

TRPV1

Studies connect Anandamide with TRPV1 at the level of receptors, enzymes, signaling, or pharmacology. This helps explain how the biology might work, but it does not prove a health outcome. 5

How strong is the research?

Not every study answers the same question

This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.

1 source

Human studies

Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.

16 sources

Reviews and evidence summaries

Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.

3 sources

Lab, animal, and mechanism research

Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.

What these studies actually looked at

The research on Anandamide is not one kind of study. This source set includes 16 narrative or expert reviews, 2 animal studies, and 2 cell or laboratory studies. 3

The recorded populations or models include animal models (5 sources), people or patients (3 sources), and cells or tissue models (2 sources). A result from one group or model should not be assumed to apply to another. 4

The most common recorded outcome focus is anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms (15 sources), cB2 receptor pharmacology, ligand binding, selectivity, or signaling mechanisms (2 sources), and gPR119 receptor activity, binding, signaling, metabolic physiology, or pharmacology (2 sources). Closely related outcome names can still describe different measurements. 5

The Anandamide source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 6

Examples from the literature

What did the studies actually look at?

Each example names the research question and the study details recorded for that source.

narrative or expert review

Amygdala FAAH and anandamide: mediating protection and recovery from stress.

On this page, this source examines Anandamide and anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 1

Study type
narrative or expert review
Outcome focus
anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

narrative or expert review

Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities.

On this page, this source examines Anandamide and anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 2

Study type
narrative or expert review
Outcome focus
anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
Evidence stage
evidence still limited

narrative or expert review

Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.

On this page, this source examines Anandamide activity involving CB2. 3

Study type
narrative or expert review
Population or model
animal models
Outcome focus
cB2 receptor pharmacology, ligand binding, selectivity, or signaling mechanisms
Evidence stage
evidence still limited

narrative or expert review

N-acylethanolamines, anandamide and food intake.

On this page, this source examines Anandamide activity involving GPR119. 4

Study type
narrative or expert review
Outcome focus
gPR119 receptor activity, binding, signaling, metabolic physiology, or pharmacology
Evidence stage
evidence still limited

narrative or expert review

TRPV1 Channel: A Potential Drug Target for Treating Epilepsy.

On this page, this source examines Anandamide activity involving TRPV1. 5

Study type
narrative or expert review
Population or model
people or patients
Outcome focus
tRPV1 channel activity, desensitization, binding, signaling, or pharmacology
Evidence stage
evidence still limited

Safety and limits

What should readers keep in mind?

Research on Anandamide should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2

Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.

Drug interactions Pregnancy and children Driving and impairment All safety topics

Common questions

Questions people ask

What is Anandamide?

Anandamide is a cannabinoid-related compound studied across Anandamide biology and metabolism, CB2, GPR119, and TRPV1. This page separates those research questions so they are not mistaken for one broad claim. 7

What has Anandamide been studied for?

The current source set includes Anandamide biology and metabolism, CB2, GPR119, and TRPV1. Each area may use different doses, products, routes, populations, and outcome measures. 8

How strong is the research on Anandamide?

Most of the current evidence is preclinical or focused on biological mechanisms. 9

Is Anandamide safe?

Safety cannot be answered for Anandamide without context. Dose, route, formulation, medications, and the person using it can all change risk. 10

Sources

Read the research

The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.

  1. 1
    Amygdala FAAH and anandamide: mediating protection and recovery from stress. narrative or expert review; evidence still limited PubMed 24325918 DOI 10.1016/j.tips.2013.08.008
  2. 2
    Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. narrative or expert review; evidence still limited PubMed 36150527 DOI 10.1016/j.plipres.2022.101194
  3. 3
    Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. narrative or expert review; evidence still limited PubMed 16678907 DOI 10.1016/j.plipres.2006.03.003
  4. 4
    N-acylethanolamines, anandamide and food intake. narrative or expert review; evidence still limited PubMed 19413995 DOI 10.1016/j.bcp.2009.04.024
  5. 5
    TRPV1 Channel: A Potential Drug Target for Treating Epilepsy. narrative or expert review; evidence still limited PubMed 26411767 DOI 10.2174/1570159x13666150216222543
  6. 6
    Anandamide and its metabolites: what are their roles in the kidney? narrative or expert review; evidence still limited PubMed 27100705 DOI 10.2741/s461
  7. 7
    Anandamide receptors. narrative or expert review; evidence still limited PubMed 12052051 DOI 10.1054/plef.2001.0349
  8. 8
    Anandamide uptake explained? narrative or expert review; evidence still limited PubMed 22297258 DOI 10.1016/j.tips.2012.01.001
  9. 9
    Chemical probes of endocannabinoid metabolism. narrative or expert review; evidence still limited PubMed 23512546 DOI 10.1124/pr.112.006387
  10. 10
    Druggable Targets in Endocannabinoid Signaling. narrative or expert review; evidence still limited PubMed 32894511 DOI 10.1007/978-3-030-50621-6_8
  11. 11
    Endocannabinoid metabolism by cytochrome P450 monooxygenases. narrative or expert review; evidence still limited PubMed 25461979 DOI 10.1016/j.prostaglandins.2014.11.002
  12. 12
    Endocannabinoids and pregnancy. narrative or expert review; evidence still limited PubMed 20302856 DOI 10.1016/j.cca.2010.03.012
See all 20 research sources

This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.

  1. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. narrative or expert review; evidence still limited / 1 linked research note PubMed 16678907
  2. Structural requirements for cannabinoid receptor probes. narrative or expert review; evidence still limited / 1 linked research note PubMed 16596776
  3. N-acylethanolamines, anandamide and food intake. narrative or expert review; evidence still limited / 1 linked research note PubMed 19413995
  4. Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. narrative or expert review; evidence still limited / 1 linked research note PubMed 20353771
  5. TRPV1 Channel: A Potential Drug Target for Treating Epilepsy. narrative or expert review; evidence still limited / 1 linked research note PubMed 26411767
  6. Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. narrative or expert review; evidence still limited / 1 linked research note PubMed 36150527
  7. Metabolism of endocannabinoids. narrative or expert review; evidence still limited / 1 linked research note PubMed 27516570
  8. Anandamide uptake explained? narrative or expert review; evidence still limited / 1 linked research note PubMed 22297258
  9. Anandamide receptors. narrative or expert review; evidence still limited / 1 linked research note PubMed 12052051
  10. The major endocannabinoid anandamide (AEA) induces apoptosis of human granulosa cells. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 34126378
  11. Endocannabinoid metabolism by cytochrome P450 monooxygenases. narrative or expert review; evidence still limited / 1 linked research note PubMed 25461979
  12. Endocannabinoids and pregnancy. narrative or expert review; evidence still limited / 1 linked research note PubMed 20302856
  13. Anandamide and its metabolites: what are their roles in the kidney? narrative or expert review; evidence still limited / 1 linked research note PubMed 27100705
  14. Endocannabinoids. cell or laboratory study; mechanism-focused research / 1 linked research note PubMed 35038882
  15. Cannabinoid CB1 receptors regulate salivation. animal study; mechanism-focused research / 1 linked research note PubMed 35986066
  16. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. animal study; mechanism-focused research / 1 linked research note PubMed 11470906
  17. Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors. narrative or expert review; evidence still limited / 1 linked research note PubMed 32867595
  18. Druggable Targets in Endocannabinoid Signaling. narrative or expert review; evidence still limited / 1 linked research note PubMed 32894511
  19. Chemical probes of endocannabinoid metabolism. narrative or expert review; evidence still limited / 1 linked research note PubMed 23512546
  20. Amygdala FAAH and anandamide: mediating protection and recovery from stress. narrative or expert review; evidence still limited / 1 linked research note PubMed 24325918